
Page#1
Table of Contents
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In millions, except shares in thousands and per share data in dollars)
December 31, December 31, 
 2017  2016
ASSETS 
Current assets: 
Cash and cash equivalents $ 4,072  $ 3,930
Premium and trade receivables 3,413  3,215
Short-term investments 531  505
Other current assets 687  715
Total current assets 8,703  8,365
Long-term investments 5,312  4,545
Restricted deposits 135  138
Property, software and equipment, net 1,104  797
Goodwill 4,749  4,712
Intangible assets, net 1,398  1,545
Other long-term assets 454  95
Total assets $ 21,855  $ 20,197
LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS’ EQUITY 
Current liabilities: 
Medical claims liability $ 4,286  $ 3,929
Accounts payable and accrued expenses 4,165  3,763
Return of premium payable 549  614
Unearned revenue 328  313
Current portion of long-term debt 4  4
Total current liabilities 9,332  8,623
Long-term debt 4,695  4,651
Other long-term liabilities 952  869
Total liabilities 14,979  14,143
Commitments and contingencies 
Redeemable noncontrolling interests 12  145
Stockholders’ equity: 
Preferred stock, $.001 par value; authorized 10,000 shares; no shares issued or outstanding at December 31, 2017 and December 31, 2016 —  —
Common stock, $.001 par value; authorized 400,000 shares; 180,379 issued and 173,437 outstanding at December 31, 2017, and 178,134 issued and 171,919
outstanding at December 31, 2016 —  —
Additional paid-in capital 4,349  4,190
Accumulated other comprehensive loss (3)  (36)
Retained earnings 2,748  1,920
Treasury stock, at cost (6,942 and 6,215 shares, respectively) (244)  (179)
Total Centene stockholders’ equity 6,850  5,895
Noncontrolling interest 14  14
Total stockholders’ equity 6,864  5,909
Total liabilities, redeemable noncontrolling interests and stockholders’ equity $ 21,855  $ 20,197
The accompanying notes to the consolidated financial statements are an integral part of these statements. 
64
Page#2
Table of Contents
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(In millions, except per share data in dollars)
 Year Ended December 31,
 2017  2016  2015
Revenues: 
Premium $ 43,353  $ 35,399  $ 19,389
Service 2,267  2,180  1,876
Premium and service revenues 45,620  37,579  21,265
Premium tax and health insurer fee 2,762  3,028  1,495
Total revenues 48,382  40,607  22,760
Expenses: 
Medical costs 37,851  30,636  17,242
Cost of services 1,847  1,864  1,621
Selling, general and administrative expenses 4,446  3,676  1,802
Amortization of acquired intangible assets 156  147  24
Premium tax expense 2,883  2,563  1,151
Health insurer fee expense —  461  215
Total operating expenses 47,183  39,347  22,055
Earnings from operations 1,199  1,260  705
Other income (expense): 
Investment and other income 190  114  35
Interest expense (255)  (217)  (43)
Earnings from continuing operations, before income tax expense 1,134  1,157  697
Income tax expense 326  599  339
Earnings from continuing operations, net of income tax expense 808  558  358
Discontinued operations, net of income tax expense (benefit) —  3  (1)
Net earnings 808  561  357
(Earnings) loss attributable to noncontrolling interests 20  1  (2)
Net earnings attributable to Centene Corporation $ 828  $ 562  $ 355
 
Amounts attributable to Centene Corporation common shareholders: 
Earnings from continuing operations, net of income tax expense $ 828  $ 559  $ 356
Discontinued operations, net of income tax expense (benefit) —  3  (1)
Net earnings $ 828  $ 562  $ 355
Net earnings (loss) per common share attributable to Centene Corporation:
Basic: 
Continuing operations $ 4.80  $ 3.50  $ 2.99
Discontinued operations —  0.02  (0.01)
Basic earnings per common share $ 4.80  $ 3.52  $ 2.98
 
Diluted: 
Continuing operations $ 4.69  $ 3.41  $ 2.89
Discontinued operations —  0.02  (0.01)
Diluted earnings per common share $ 4.69  $ 3.43  $ 2.88
 
The accompanying notes to the consolidated financial statements are an integral part of these statements.
65
Page#3
Table of Contents
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
 Year Ended December 31,
 2017  2016  2015
Cash flows from operating activities: 
Net earnings $ 808  $ 561  $ 357
Adjustments to reconcile net earnings to net cash provided by operating activities 
Depreciation and amortization 361  278  111
Stock compensation expense 135  148  71
Debt extinguishment costs —  (7)  —
Deferred income taxes (108)  92  (17)
Gain on contingent consideration (1)  (5)  (44)
Goodwill and intangible adjustment —  —  38
Changes in assets and liabilities 
Premium and trade receivables (50)  74  (360)
Other assets (146)  167  (102)
Medical claims liabilities 359  145  536
Unearned revenue 19  43  (27)
Accounts payable and accrued expenses 53  402  39
Other long-term liabilities 68  (61)  51
Other operating activities, net (9)  14  5
Net cash provided by operating activities 1,489  1,851  658
Cash flows from investing activities: 
Capital expenditures (422)  (306)  (150)
Purchases of investments (2,704)  (2,450)  (1,321)
Sales and maturities of investments 1,899  1,656  669
Investments in acquisitions, net of cash acquired (50)  (1,297)  (18)
Other investing activities, net 12  —  7
Net cash used in investing activities (1,265)  (2,397)  (813)
Cash flows from financing activities: 
Proceeds from borrowings 1,400  8,946  1,925
Payment of long-term debt (1,353)  (6,076)  (1,583)
Common stock repurchases (65)  (63)  (53)
Purchase of noncontrolling interest (66)  (14)  —
Debt issuance costs (3)  (76)  (4)
Other financing activities, net 5  —  20
Net cash (used in) provided by financing activities (82)  2,717  305
Effect of exchange rate changes on cash and cash equivalents —  (1)  —
Net increase in cash and cash equivalents 142  2,170  150
Cash and cash equivalents, beginning of period 3,930  1,760  1,610
Cash and cash equivalents, end of period $ 4,072  $ 3,930  $ 1,760
Supplemental disclosures of cash flow information: 
Interest paid $ 237  $ 165  $ 55
Income taxes paid $ 496  $ 556  $ 328
Equity issued in connection with acquisitions $ —  $ 3,105  $ 12
 
The accompanying notes to the consolidated financial statements are an integral part of these statements.
68